Peptide laws in Thailand
Last updated: October 3, 2026 · 5 min read · By the Grey Peptides Editorial Board
- Injectable GLP-1 medicines became specially controlled drugs in Thailand on September 15, 2026, dispensed only on a doctor's prescription.
- The rule was made by a Ministry of Public Health notification published in the Royal Gazette on March 18, 2026, with a 180-day delay.
- Research peptides such as BPC-157 are unregistered medicines in Thailand.
- Each status on this page is dated and sourced.
How Thailand regulates medicines
Medicines in Thailand are regulated under the Drug Act by the Food and Drug Administration within the Ministry of Public Health. A medicine must be registered before it may be sold, and registered medicines fall into classes that decide how they are supplied: ordinary household remedies, pharmacy medicines, dangerous drugs and, at the strictest level short of narcotics, specially controlled drugs, which may be supplied only on a doctor's prescription 1.
That classification is what changed for GLP-1 medicines in 2026, and it is the framework against which any peptide sold in Thailand has to be judged.
The 2026 specially controlled drug rule
On March 18, 2026, the Royal Gazette published the Ministry of Public Health Notification on Specially Controlled Drugs (No. 58), signed by the Minister of Public Health on March 6, 2026 on the recommendation of the Drug Committee. As reproduced in the Thai press and in an English translation, it adds, as item (100) of article 3 of the 1978 specially controlled drugs notification, the injectable glucagon-like peptide-1 (GLP-1) drug group, and provides that it takes effect 180 days after the day following publication 1. That date was September 15, 2026 2.
At a press conference on September 14, 2026, the FDA's secretary-general explained the change: GLP-1 receptor agonists such as liraglutide and semaglutide, known publicly as weight-loss pens, are indicated for type 2 diabetes and, for some products, for weight control in obesity, but were being used for weight loss without medical assessment or supervision, alongside counterfeit products, products of unknown origin and online selling 2. From September 15, a modern pharmacy may sell them only against a doctor's prescription, dispensed by a pharmacist, and the FDA said it is extending its Track and Trace system to follow the products through the supply chain, with penalties including imprisonment and fines 2.
The Royal Gazette's own site refused our requests, so the wording above is taken from Thai press reproductions and a published English translation rather than from the gazette PDF, and is described as reported rather than quoted 1.
Research peptides
Research peptides such as BPC-157, TB-500 and retatrutide are not registered medicines in Thailand, and we found no Thai FDA statement specific to them, so this page does not describe one 3. Under the Drug Act framework, selling or importing for sale a medicine that has not been registered is not lawful, and a product sold as a research chemical does not escape that by being labelled for research.
The FDA's stated concerns about the GLP-1 market, counterfeits, unknown sources and online selling, apply with greater force to peptides that no regulator has assessed at all 2. Our manufacturing guide covers what analyses have found in such material.
What the FDA says it is enforcing
The FDA presented the September change as one part of a package rather than a single rule. Alongside the prescription requirement, it described extending the Track and Trace system so that products can be followed through the supply chain, and continuing action against illegal advertising and unlicensed selling, which it said had persisted despite earlier enforcement 2. It set out the clinical reasoning too: stopping or self-adjusting the medicine without advice can mean rapid weight regain, and it listed low blood sugar, pancreatitis, kidney failure, depression and muscle loss among the risks of misuse, which it said could be life-threatening in people with underlying conditions 2.
Two practical tests follow for anyone buying in Thailand. Was the product dispensed by a pharmacist against a prescription, and can the seller account for where it came from? A product failing either test is outside the system the FDA has just built.
Travellers and personal supply
Thailand is a common destination for people who buy medicines while travelling. Two points follow from the 2026 change. A GLP-1 pen is now in a class that a pharmacy may dispense only against a prescription, so buying one over the counter is not the position it may once have been 2. And a medicine bought in a Thai pharmacy is subject to the rules of your own country when you carry it home; our travel guide covers what those rules generally require.
Sport
Thai athletes are subject to the WADA Prohibited List through the national anti-doping organisation. BPC-157 is caught by the S0 catch-all, and growth hormone secretagogues and releasing peptides are named under S2.2.4; GLP-1 receptor agonists are not prohibited 3. Our WADA hub lists each peptide.
Thailand in context
Thailand's move is part of a 2026 pattern across jurisdictions: regulators tightening how GLP-1 medicines reach people rather than withdrawing the medicines. China's revised drug regulations closed online retail and online prescribing of higher-risk injectables in May 2026, and Japan's health ministry issued notices on off-label cosmetic use in June 2026. Our China page, Japan page and legal overview set those out.
Questions to check
- Is the product registered with the Thai FDA, and for the indication offered?
- Is a pharmacy dispensing an injectable GLP-1 medicine against a doctor's prescription, as the September 2026 rule requires?
- Does the seller have a traceable supply chain, or is the product of unknown origin?
- What are the rules in my own country for carrying the medicine home?
- Am I subject to anti-doping rules?
The bottom line
Since September 15, 2026, injectable GLP-1 medicines have been specially controlled drugs in Thailand, dispensed only on a doctor's prescription, after a Royal Gazette notification published in March 2026 with a 180-day delay. The Thai FDA framed the change around weight-loss use without medical assessment, counterfeits and online selling. Research peptides remain unregistered medicines.
Frequently asked questions
Are peptides legal in Thailand?
Registered peptide medicines are legal through the proper supply route. Research peptides such as BPC-157 are not registered medicines in Thailand.
Do you need a prescription for Ozempic in Thailand?
Since September 15, 2026, injectable GLP-1 medicines are specially controlled drugs, so a pharmacy may dispense them only against a doctor's prescription.
What is a specially controlled drug in Thailand?
The strictest class short of narcotics under the Drug Act framework: supplied only on a doctor's prescription.
When did Thailand's GLP-1 rule take effect?
On September 15, 2026, 180 days after the Royal Gazette published the notification on March 18, 2026.
Can I buy weight-loss pens over the counter in Thailand?
Not since the September 2026 change; a prescription is required and a pharmacist must dispense.
Related on Grey Peptides
Sources
- Ministry of Public Health (Thailand). Notification on Specially Controlled Drugs (No. 58), signed March 6, 2026, published in the Royal Gazette March 18, 2026, adding item (100), injectable glucagon-like peptide-1 (GLP-1) drugs, effective 180 days after publication. Royal Gazette site refused our requests (HTTP 403); text as reproduced and translated by Thairath (English), Thai Post and Hfocus. Read October 3, 2026.
- Thai Food and Drug Administration press conference, September 14, 2026 (reported by Bangkok Biznews and Hfocus): injectable GLP-1 medicines specially controlled from September 15, 2026; prescription required and dispensing by a pharmacist; Track and Trace extension; penalties. Read October 3, 2026.
- Grey Peptides encyclopedia and WADA hub: no approval recorded for BPC-157, TB-500 or retatrutide in any jurisdiction we track; WADA sections S0 and S2.2.4; GLP-1 receptor agonists not prohibited. Read October 3, 2026.
Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.
New guides and rule changes, by email
One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.
We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead